Berallo, Jeaih Guadette S.
HRN: 14-72-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
CEFTRIAXONE 1G (VIAL)
09/13/2023
09/19/2023
IV
900mg
Q12
Pcap C, Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes